Android-to-gynoid lean mass ratio

1. Android-to-gynoid lean mass ratio is associated with stage 4 cardiovascular-kidney-metabolic syndrome in humans (OR 1.83, 95% CI 1.34–2.50).

   “Higher AGLR was associated with stage 4 of CKM syndrome (OR = 1.83, 95% CI: 1.34‒2.50, p < 0.001).”

   Humansn = 7,399

   Association between android-to-gynoid lean mass ratio and advanced cardiovascular-kidney-metabolic syndrome, and the cross-sectional association decomposition of estimated glucose disposal rate

   Clinics (Sao Paulo, Brazil)·15 Oct 2026

More on Stage 4 cardiovascular-kidney-metabolic syndrome